Alzheimer disease (AD) increases exponentially with age, with an annual
incidence of approximately 0.08% at age 60 to 64 years, and more than doubling
every 5 years to an incidence of 0.7% at age 75 to 79 years and 1.4% at age
80 to 85 years.1 Approximately 43% of people
with AD are between 75 and 85 years.1 A substantial
number of observational studies have suggested that hormone therapy decreases
incidence or delays onset of dementia, primarily AD.2- 7 Laboratory
studies have shown that estrogen receptors are present on cholinergic neurons
and have neurotropic, antioxidant, and anti-inflammatory effects.8,9 Estrogen deficiency in middle age has
been postulated to account, at least in part, for the somewhat higher incidence
of AD in women than men and may constitute a risk factor for AD.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 16
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.